Literature DB >> 28121216

Left ventricular function at two-year follow-up in treatment-naive rheumatoid arthritis patients is associated with anti-cyclic citrullinated peptide antibody status: a cohort study.

B B Løgstrup1,2, D Masic2, T B Laurbjerg2, J Blegvad2, M Herly2, L D Kristensen2, G Urbonaviciene2, A Hedemann-Nielsen2, T Ellingsen3,4.   

Abstract

OBJECTIVES: In rheumatoid arthritis (RA), the role of autoimmunity, especially anti-cyclic citrullinated peptide antibody (anti-CCP) level, and the time-course of left ventricular (LV) function is unknown. The objective was to assess LV function and the amount of coronary calcium in relation to anti-CCP levels in a cohort of treatment-naive RA patients, and to assess changes in these parameters during a 2 year follow-up period.
METHOD: Sixty-six steroid- and disease-modifying anti-rheumatic drug-naive RA patients were treated with methotrexate according to the Danish national guidelines. We assessed LV function by conventional echocardiography and speckle-tracking echocardiography. We estimated the amount and progression of coronary calcium by coronary computed tomography. Patients were examined at the time of diagnosis and after 2 years.
RESULTS: Patients with elevated anti-CCP at baseline and after 2 years, compared to those with non-persistently elevated anti-CCP, had significantly less improvement in S´ (1 ± 1.4 cm/s vs 0.2 ± 0.9 cm/s; p = 0.04) and a worsening in global longitudinal systolic strain (GLS) (0.6 ± 1.8% vs -1 ± 2.8%; p = 0.04). There was a significant correlation between ΔGLS over 2 years and anti-CCP at 2 year follow-up (r = 0.36; p = 0.006). We observed a small progression of coronary calcium score during the 2 year follow-up period. No differences in progression were found between patients with high anti-CCP titres at baseline and 2 year follow-up (n = 12) and patients with normal/low anti-CCP titres (n = 32) (23.8 ± 40.3 vs 22.6 ± 68.9; p = 0.96).
CONCLUSIONS: Deformation analysis by speckle-tracking echocardiography is a valuable tool to detect early development of myocardial dysfunction despite normal ejection fraction in RA.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28121216     DOI: 10.1080/03009742.2016.1249941

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  4 in total

1.  2-D speckle-tracking assessment of left and right ventricular function in rheumatoid arthritis patients with and without disease activity.

Authors:  Mohamed Naseem; Sameh Samir; Ibtsam Khairat Ibrahim; Lamiaa Khedr; Abeer Abd Elmonem Shahba
Journal:  J Saudi Heart Assoc       Date:  2018-11-16

2.  Anti-modified citrullinated vimentin antibody: a novel biomarker associated with cardiac systolic dysfunction in patients with rheumatoid arthritis.

Authors:  Somayye Norouzi; Ali Javinani; Arya Aminorroaya; Maryam Masoumi
Journal:  BMC Cardiovasc Disord       Date:  2020-08-26       Impact factor: 2.298

3.  Cardiovascular effects of biological versus conventional synthetic disease-modifying antirheumatic drug therapy in treatment-naïve, early rheumatoid arthritis.

Authors:  Sven Plein; Bara Erhayiem; Graham Fent; Sarah Horton; Raluca Bianca Dumitru; Jacqueline Andrews; John P Greenwood; Paul Emery; Elizabeth Ma Hensor; Paul Baxter; Sue Pavitt; Maya H Buch
Journal:  Ann Rheum Dis       Date:  2020-08-28       Impact factor: 19.103

4.  A preliminary study on the evaluation of left atrial function of rheumatoid arthritis by two dimensional speckle tracking imaging.

Authors:  Xiang Ji; Xia Zhang; Guojie Li
Journal:  Sci Rep       Date:  2021-11-02       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.